Cutting Costs for CML Abroad

Cutting Costs for CML Abroad

“If you have to get cancer,” I once reassured a frightened patient, “CML [chronic myeloid leukemia] isn’t bad.” CML is truly one of our cancer success stories. The identification of a single genetic swap — BCR-ABL — and the development of tyrosine kinase inhibitors...

The Roman God of Portals and More

The Roman God of Portals and More

In 1951 a renowned hematologist from Harvard University, William Dameshek, MD, wrote an editorial in Blood providing seminal insight into myeloproliferative neoplasms (MPNs) — a group of disorders characterized by expansion of different myeloid lineages, with...

One-Size-Fits-All for AML? Not Anymore

Once upon a time, there was “7+3.” Developed in the 1970s, this easy-to-remember induction chemotherapy regimen for acute myeloid leukemia (AML) went largely unchanged for decades. But in the past few years, we have seen multiple new drug approvals, and not just for...

I AM IRONMAN!

If you’re a nerd like... Scratch that...If you’re in Orlando this week, it’s either because you have a favorite blood cell type (gotta be the sea blue histiocyte) or you still haven’t given up on your childhood dream of being a Disney hero/heroine (my Halloween...

Share This